Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Jun-24 6:05 PM View:  | Manhattan Pharmaceuticals I... (TGTX) | 19-Jun-24 | Grant | 22,250 | -- | -- | 9% 242.69K to 264.94K | |
| 13-Jun-24 4:22 PM View: | Nuvectis Pharma, Inc. (NVCT) | 13-Jun-24 | Grant | 30,000 | -- | -- | 41% 73.14K to 103.14K | |
| 29-Sep-23 5:01 PM View: | Manhattan Pharmaceuticals I... (TGTX) | 28-Sep-23 | Grant | 20,000 | -- | -- | 9% 222.69K to 242.69K | |
| 20-Jun-23 8:15 AM View: | Nuvectis Pharma, Inc. (NVCT) | 16-Jun-23 | Grant | 18,000 | -- | -- | 33% 55.14K to 73.14K | |
| 22-Jul-22 4:31 PM View: | Manhattan Pharmaceuticals I... (TGTX) | 20-Jul-22 | Grant | 43,732 | -- | -- | 24% 178.95K to 222.69K | |
| 16-May-22 8:33 AM View: | Nuvectis Pharma, Inc. (NVCT) | 12-May-22 | Purchase | 6,000 | $17.40 | $104,400.00 | 12% 49.14K to 55.14K | |
| 22-Jun-21 6:25 PM View: | Manhattan Pharmaceuticals I... (TGTX) | 18-Jun-21 | Grant | 20,000 | -- | -- | 13% 158.95K to 178.95K | |
| 24-Jun-20 7:50 PM View: | Manhattan Pharmaceuticals I... (TGTX) | 22-Jun-20 | Grant | 15,000 | -- | -- | 10% 143.95K to 158.95K | |
| 10-Jun-20 11:18 AM View: | Stemline Therapeutics Inc (STML) | 10-Jun-20 | Grant | 600,000 | -- | -- | 77% 774.35K to 1.37M | |
| 10-Jun-20 11:18 AM View: | Stemline Therapeutics Inc (STML) | 10-Jun-20 | Disposition (change in control) | 1,374,350 | -- | -- | (100%) 1.37M to 0 | |
| 13-Mar-20 9:31 PM View: | Stemline Therapeutics Inc (STML) | 10-Mar-20 | Sale | 16,704 | $4.91 | $82,016.60 | (2%) 788.47K to 771.76K | |
| 13-Mar-20 9:31 PM View: | Stemline Therapeutics Inc (STML) | 09-Mar-20 | Sale | 9,487 | $5.08 | $48,194.00 | (1%) 797.96K to 788.47K | |
| 28-Feb-20 9:31 PM View: | Stemline Therapeutics Inc (STML) | 25-Feb-20 | Sale | 11,547 | $6.42 | $74,131.70 | (1%) 809.5K to 797.96K | |
| 14-Feb-20 9:29 PM View: | Stemline Therapeutics Inc (STML) | 10-Feb-20 | Grant | 208,417 | -- | -- | 35% 601.09K to 809.5K | |
| 24-Jan-20 9:31 PM View: | Stemline Therapeutics Inc (STML) | 22-Jan-20 | Sale | 22,139 | $7.02 | $155,416.00 | (4%) 623.22K to 601.09K | |
| 10-Jan-20 9:16 PM View: | Stemline Therapeutics Inc (STML) | 08-Jan-20 | Sale | 13,228 | $10.37 | $137,174.00 | (2%) 636.45K to 623.22K | |
| 03-Jan-20 5:19 PM View: | Stemline Therapeutics Inc (STML) | 27-Dec-19 | Sale | 2,022 | $10.48 | $21,190.60 | (< 1%) 638.47K to 636.45K | |
| 03-Jan-20 5:19 PM View: | Stemline Therapeutics Inc (STML) | 26-Dec-19 | Sale | 15,494 | $10.75 | $166,560.00 | (2%) 653.97K to 638.47K | |
| 03-Jan-20 5:19 PM View: | Stemline Therapeutics Inc (STML) | 24-Dec-19 | Sale | 24,477 | $10.97 | $268,513.00 | (4%) 678.45K to 653.97K | |
| 03-Jan-20 5:19 PM View: | Stemline Therapeutics Inc (STML) | 23-Dec-19 | Sale | 4,319 | $10.58 | $45,695.00 | (< 1%) 682.76K to 678.45K | |
| 18-Sep-19 5:11 PM View: | Manhattan Pharmaceuticals I... (TGTX) | 17-Sep-19 | Grant | 27,048 | -- | -- | 23% 116.91K to 143.95K | |
| 28-Jun-19 5:17 PM View: | Stemline Therapeutics Inc (STML) | 26-Jun-19 | Market Sale | 12,508 | $14.77 | $184,743.00 | (2%) 695.27K to 682.76K | |
| 28-Jun-19 5:17 PM View: | Stemline Therapeutics Inc (STML) | 25-Jun-19 | Private Sale | 25,500 | $15.07 | $384,285.00 | (4%) 720.77K to 695.27K | |
| 28-Jun-19 5:17 PM View: | Stemline Therapeutics Inc (STML) | 24-Jun-19 | Private Sale | 9,107 | $15.49 | $141,067.00 | (1%) 729.88K to 720.77K | |
| 17-May-19 9:29 PM View: | Stemline Therapeutics Inc (STML) | 14-May-19 | Market Sale | 25,817 | $14.27 | $368,409.00 | (3%) 755.7K to 729.88K | (2%) |
| 15-Mar-19 9:00 PM View: | Stemline Therapeutics Inc (STML) | 12-Mar-19 | Market Sale | 981 | $11.04 | $10,830.20 | (< 1%) 756.68K to 755.7K | (22%) |
| 15-Mar-19 9:00 PM View: | Stemline Therapeutics Inc (STML) | 11-Mar-19 | Market Sale | 25,101 | $11.11 | $278,872.00 | (3%) 781.78K to 756.68K | (21%) |
| 08-Mar-19 9:31 PM View: | Stemline Therapeutics Inc (STML) | 07-Mar-19 | Market Sale | 2,995 | $11.36 | $34,023.20 | (< 1%) 784.77K to 781.78K | 3% |
| 27-Feb-19 9:10 PM View: | Stemline Therapeutics Inc (STML) | 25-Feb-19 | Market Sale | 10,557 | $12.05 | $127,212.00 | (1%) 795.33K to 784.77K | 3% |
| 08-Feb-19 8:54 PM View: | Stemline Therapeutics Inc (STML) | 06-Feb-19 | Grant | 148,678 | -- | -- | 23% 646.65K to 795.33K | |
| 11-Jan-19 9:30 PM View: | Stemline Therapeutics Inc (STML) | 08-Jan-19 | Market Sale | 13,547 | $10.15 | $137,502.00 | (2%) 660.2K to 646.65K | (13%) |
| 30-Nov-18 8:59 PM View: | Stemline Therapeutics Inc (STML) | 26-Nov-18 | Market Sale | 26,296 | $11.85 | $311,608.00 | (4%) 686.03K to 659.74K | 3% |
| 14-Sep-18 9:58 PM View: | Stemline Therapeutics Inc (STML) | 12-Sep-18 | Grant | 275,000 | -- | -- | 67% 411.03K to 686.03K | |
| 28-Jun-18 5:00 PM View: | Manhattan Pharmaceuticals I... (TGTX) | 26-Jun-18 | Grant | 15,000 | -- | -- | 15% 101.91K to 116.91K | |
| 14-Mar-18 9:30 PM View: | Stemline Therapeutics Inc (STML) | 13-Mar-18 | Market Sale | 12,746 | $16.82 | $214,388.00 | (3%) 422.34K to 409.59K | 32% |
| 14-Mar-18 9:30 PM View: | Stemline Therapeutics Inc (STML) | 12-Mar-18 | Market Sale | 17,241 | $17.38 | $299,697.00 | (4%) 439.58K to 422.34K | 34% |
| 09-Mar-18 9:32 PM View: | Stemline Therapeutics Inc (STML) | 08-Mar-18 | Grant | 70,303 | -- | -- | 19% 369.28K to 439.58K | |
| 09-Mar-18 9:32 PM View: | Stemline Therapeutics Inc (STML) | 07-Mar-18 | Market Sale | 3,027 | $16.55 | $50,096.80 | (< 1%) 372.31K to 369.28K | 31% |
| 28-Feb-18 9:31 PM View: | Stemline Therapeutics Inc (STML) | 27-Feb-18 | Market Sale | 5,726 | $17.26 | $98,830.80 | (2%) 377.64K to 371.92K | 33% |
| 28-Feb-18 9:31 PM View: | Stemline Therapeutics Inc (STML) | 26-Feb-18 | Market Sale | 5,300 | $17.61 | $93,333.00 | (1%) 382.94K to 377.64K | 35% |
| 16-Feb-18 9:31 PM View: | Stemline Therapeutics Inc (STML) | 15-Feb-18 | Market Sale | 1,851 | $15.67 | $29,005.20 | (< 1%) 384.79K to 382.94K | 27% |
| 12-Jan-18 9:31 PM View: | Stemline Therapeutics Inc (STML) | 08-Jan-18 | Market Sale | 14,040 | $13.93 | $195,577.00 | (4%) 398.83K to 384.79K | 18% |
| 19-Dec-17 7:58 PM View: | Stemline Therapeutics Inc (STML) | 18-Dec-17 | Market Sale | 40 | $14.75 | $590.00 | (< 1%) 398.87K to 398.83K | 22% |
| 19-Dec-17 7:58 PM View: | Stemline Therapeutics Inc (STML) | 15-Dec-17 | Market Sale | 11,943 | $14.18 | $169,352.00 | (3%) 410.81K to 398.87K | 19% |
| 19-Jun-17 6:10 PM View: | Manhattan Pharmaceuticals I... (TGTX) | 16-Jun-17 | Grant | 15,000 | -- | -- | 17% 86.91K to 101.91K | |
| 09-Mar-17 9:33 PM View: | Stemline Therapeutics Inc (STML) | 09-Mar-17 | Grant | 131,469 | -- | -- | 47% 277.67K to 409.14K | |
| 09-Mar-17 9:33 PM View: | Stemline Therapeutics Inc (STML) | 07-Mar-17 | Market Sale | 2,342 | $8.16 | $19,110.70 | (< 1%) 280.02K to 277.67K | (41%) |
| 01-Mar-17 9:53 PM View: | Stemline Therapeutics Inc (STML) | 28-Feb-17 | Market Sale | 4,027 | $7.01 | $28,229.30 | (1%) 283.68K to 279.65K | (64%) |
| 01-Mar-17 9:53 PM View: | Stemline Therapeutics Inc (STML) | 27-Feb-17 | Market Sale | 4,000 | $6.97 | $27,880.00 | (1%) 287.68K to 283.68K | (65%) |
| 17-Feb-17 9:03 PM View: | Stemline Therapeutics Inc (STML) | 16-Feb-17 | Market Sale | 1,508 | $6.42 | $9,681.36 | (< 1%) 289.19K to 287.68K | (79%) |